Edition:
United Kingdom

Daiichi Sankyo Co Ltd (4568.T)

4568.T on Tokyo Stock Exchange

2,854JPY
4:26am GMT
Change (% chg)

¥11 (+0.39%)
Prev Close
¥2,844
Open
¥2,848
Day's High
¥2,855
Day's Low
¥2,828
Volume
859,800
Avg. Vol
2,507,262
52-wk High
¥2,855
52-wk Low
¥2,284

Latest Key Developments (Source: Significant Developments)

R&I affirms Daiichi Sankyo's rating at "AA" and says negative outlook-R&I
Friday, 1 Dec 2017 

Dec 1 (Reuters) - Daiichi Sankyo Co Ltd <4568.T>:Rating and Investment Information, Inc. (R&I) affirmed the company's rating at "AA"-R&I.Rating outlook negative-R&I.  Full Article

Daiichi Sankyo to merge with unit Asubio Pharma
Thursday, 30 Nov 2017 

Nov 30 (Reuters) - Daiichi Sankyo Co Ltd <4568.T>:Says it will merge with wholly owned unit Asubio Pharma Co., Ltd., effective April 1, 2018 .Says unit will be dissolved after merger .  Full Article

IM to buy IM DIGITAL PHIL for 5.43 bln won
Monday, 27 Nov 2017 

Nov 27 (Reuters) - IM Co Ltd <101390.KQ> ::Says it plans to buy IM DIGITAL PHIL, Inc, a Philippine Auto Focus Module firm, for 5.43 billion won .  Full Article

Daiichi Sankyo to repurchase shares for up to 50 bln yen
Tuesday, 31 Oct 2017 

Oct 31(Reuters) - Daiichi Sankyo Co Ltd <4568.T>:Says it plans to buy back up to 28 million shares, representing 4.2 percent of outstanding, for up to 50 billion yen, during period from Nov. 1 to March 23, 2018.  Full Article

Daiichi Sankyo to buy back up to 50 bln yen of stock
Tuesday, 31 Oct 2017 

Oct 31 (Reuters) - Daiichi Sankyo <4568.T>::Says it will buy back up to 50 billion yen ($442 million) of stock through March 23.  Full Article

Daiichi Sankyo to close Japan research unit Asubio Pharma
Friday, 10 Feb 2017 

Daiichi Sankyo <4568.T>: Says to close Japan research unit Asubio Pharma .Says move aimed at further reorganising its research and development structure.  Full Article

Daiichi Sankyo Co and Inspirion Delivery Sciences LLC Announce U.S. Licensing Agreement for MorphaBond
Tuesday, 25 Oct 2016 

Daiichi Sankyo Co Ltd <4568.T>: Daiichi And Inspirion Delivery Sciences LLC announce U.S. Licensing agreement for morphabond formulated with sentrybond abuse-deterrent technology . Under terms of agreement inspirion will receive an upfront payment .Inspiron will also receive milestone payments and royalties under terms of agreement.  Full Article

Daiichi Sankyo Co Ltd, Dana-Farber Cancer Institute today announce lung cancer research collaboration
Wednesday, 12 Oct 2016 

Daiichi Sankyo Co Ltd <4568.T>: Daiichi Sankyo Co Ltd - co, Dana-Farber Cancer Institute today announced a preclinical research collaboration focused on lung cancer .Daiichi Sankyo Co Ltd - financial terms of agreement were not disclosed.  Full Article

Daiichi Sankyo Co enters into a collaboration with Agonox Inc
Tuesday, 4 Oct 2016 

Daiichi Sankyo Co Ltd <4568.T>: Financial terms of agreement were not disclosed. . Daiichi Sankyo and Agonox will collaborate on preclinical development of program of an undisclosed immuno-oncology target .Entered into a strategic collaboration with Agonox, Inc.  Full Article

Daiichi Sankyo plans 5th&6th series unsecured corporate bonds worth total 100 bln yen
Friday, 15 Jul 2016 

Daiichi Sankyo Co Ltd <4568.T> : Says it plans to issue 5th series unsecured corporate bonds worth 75 billion yen, with coupon rate of 0.810 percent and maturity date on July 25, 2036 . Says it plans to issue 6th series unsecured corporate bonds worth 25 billion yen, with coupon rate of 1.200 percent and maturity date on July 25, 2046 .Subscription date on July 15 and payment date on July 25.  Full Article

BRIEF-Daiichi Sankyo And Puma Biotechnology To Collaborate With Major Cancer Center In HER2-Mutated Cancer

* DAIICHI SANKYO AND PUMA BIOTECHNOLOGY ANNOUNCE RESEARCH COLLABORATION WITH MAJOR CANCER CENTER IN HER2-MUTATED CANCER Source text for Eikon: Further company coverage: